Literature DB >> 3027982

Multiple recombination sites at the 5'-end of murine coronavirus RNA.

J G Keck, S A Stohlman, L H Soe, S Makino, M M Lai.   

Abstract

Mouse hepatitis virus (MHV), a murine coronavirus, contains a nonsegmented RNA genome. We have previously shown that MHV could undergo RNA-RNA recombination in crosses between temperature-sensitive mutants and wild-type viruses at a very high frequency (S. Makino, J.G. Keck, S.A. Stohlman, and M.M.C. Lai (1986) J. Virol. 57, 729-737). To better define the mechanism of RNA recombination, we have performed additional crosses involving different sets of MHV strains. Three or possibly four classes of recombinants were isolated. Recombinants in the first class, which are similar to the ones previously reported, contain a single crossover in either gene A or B, which are the 5'-most genes. The second class of recombinants contain double crossovers in gene A. The third class of recombinants have crossovers within the leader sequence located at the 5'-end of the genome. The crossover sites of the third class have been located between 35 and 60 nucleotides from the 5'-end of the leader RNA. One of these recombinants has double crossovers within the short region comprising the leader sequences. Finally, we describe one recombinant which may contain a triple crossover. The presence of so many recombination sites within the 5'-end of the genome of murine coronaviruses confirms that RNA recombination is a frequent event during MHV replication and is consistent with our proposed model of "copy-choice" recombination in which RNA replication occurs in a discontinuous and nonprocessive manner.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027982      PMCID: PMC7130635          DOI: 10.1016/0042-6822(87)90413-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  17 in total

1.  Genomic RNA of the murine coronavirus JHM.

Authors:  H Wege; A Müller; V ter Meulen
Journal:  J Gen Virol       Date:  1978-11       Impact factor: 3.891

2.  Recombination between nonsegmented RNA genomes of murine coronaviruses.

Authors:  M M Lai; R S Baric; S Makino; J G Keck; J Egbert; J L Leibowitz; S A Stohlman
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

Review 3.  Rapid nucleotide sequencing of DNA.

Authors:  T Friedmann
Journal:  Am J Hum Genet       Date:  1979-01       Impact factor: 11.025

4.  High-frequency RNA recombination of murine coronaviruses.

Authors:  S Makino; J G Keck; S A Stohlman; M M Lai
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Characterization of leader RNA sequences on the virion and mRNAs of mouse hepatitis virus, a cytoplasmic RNA virus.

Authors:  M M Lai; R S Baric; P R Brayton; S A Stohlman
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

6.  Comparative analysis of RNA genomes of mouse hepatitis viruses.

Authors:  M M Lai; S A Stohlman
Journal:  J Virol       Date:  1981-05       Impact factor: 5.103

7.  Mouse hepatitis virus A59: mRNA structure and genetic localization of the sequence divergence from hepatotropic strain MHV-3.

Authors:  M M Lai; P R Brayton; R C Armen; C D Patton; C Pugh; S A Stohlman
Journal:  J Virol       Date:  1981-09       Impact factor: 5.103

8.  Sequence of the nucleocapsid gene from murine coronavirus MHV-A59.

Authors:  J Armstrong; S Smeekens; P Rottier
Journal:  Nucleic Acids Res       Date:  1983-02-11       Impact factor: 16.971

9.  Analysis of genomic and intracellular viral RNAs of small plaque mutants of mouse hepatitis virus, JHM strain.

Authors:  S Makino; F Taguchi; N Hirano; K Fujiwara
Journal:  Virology       Date:  1984-11       Impact factor: 3.616

10.  The 5'-end sequence of the murine coronavirus genome: implications for multiple fusion sites in leader-primed transcription.

Authors:  C K Shieh; L H Soe; S Makino; M F Chang; S A Stohlman; M M Lai
Journal:  Virology       Date:  1987-02       Impact factor: 3.616

View more
  42 in total

1.  Generation of coronavirus spike deletion variants by high-frequency recombination at regions of predicted RNA secondary structure.

Authors:  C L Rowe; J O Fleming; M J Nathan; J Y Sgro; A C Palmenberg; S C Baker
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Recombination between Sindbis virus RNAs.

Authors:  B G Weiss; S Schlesinger
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

Review 3.  RNA recombination in animal and plant viruses.

Authors:  M M Lai
Journal:  Microbiol Rev       Date:  1992-03

Review 4.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

5.  5'-proximal hot spot for an inducible positive-to-negative-strand template switch by coronavirus RNA-dependent RNA polymerase.

Authors:  Hung-Yi Wu; David A Brian
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

6.  Generation and analysis of nonhomologous RNA-RNA recombinants in brome mosaic virus: sequence complementarities at crossover sites.

Authors:  J J Bujarski; A M Dzianott
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

7.  Template-switching during DNA synthesis by Thermus aquaticus DNA polymerase I.

Authors:  S J Odelberg; R B Weiss; A Hata; R White
Journal:  Nucleic Acids Res       Date:  1995-06-11       Impact factor: 16.971

8.  High-frequency leader sequence switching during coronavirus defective interfering RNA replication.

Authors:  S Makino; M M Lai
Journal:  J Virol       Date:  1989-12       Impact factor: 5.103

9.  Sequence and translation of the murine coronavirus 5'-end genomic RNA reveals the N-terminal structure of the putative RNA polymerase.

Authors:  L H Soe; C K Shieh; S C Baker; M F Chang; M M Lai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

10.  RNA recombination in a coronavirus: recombination between viral genomic RNA and transfected RNA fragments.

Authors:  C L Liao; M M Lai
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.